Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could your phone diagnose sleep apnea? new study puts app to the test

NCT ID NCT06474143

Diagnosis Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether a smartphone app called Apneal can accurately diagnose sleep apnea. 491 adults wore the app on their chest during an overnight sleep test, and the app's results were compared to the standard hospital sleep test. The goal is to see if the app can reliably categorize sleep apnea severity, potentially offering a more convenient at-home diagnosis option.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Apneal smartphone application
What this could lead to
If successful, this could provide a simpler, more accessible way to diagnose sleep apnea at home, reducing the need for overnight hospital stays.
What could go wrong
The app may not be as accurate as the standard test, and results might vary depending on phone model or user behavior. This was a completed study, so results are pending.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

491 people

The number who actually took part.

Started

Feb 2024

Finished

Mar 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals, men or women, aged over 18 and with no upper age limit; * Individuals for whom PSG is indicated as part of routine care, regardless of indication. * Individuals willing and able to comply with study requirements; * Individuals with a declared total sleep time of at least 6 hours, as recommended by AASM for PSG analysis. * Individuals affiliated to social security or beneficiary of such a scheme if applicable according to the local regulation ; * Voluntary individuals who have provided oral and written consent after being informed by the research investigator. Exclusion Criteria: * Individuals with active implantable medical devices (e.g. electronic heart implant, electrical neurophysiological stimulator…); * Individuals with mechanical heart valves; * Individuals with chest deformity preventing the phone to be correctly placed on the chest * Individuals with uncontrolled psychiatric conditions impairing their ability to fully consent to the study * Individuals suffering from epilepsy or an associated disorder; * Individuals suffering from a moderate to severe valvular disease; * Individuals under CPAP treatment during the participation. * Individuals suffering from a nervous system disorder that causes unintended or uncontrollable movements, other than periodic leg movement syndrome and restless leg syndrome. * Refusal to participate in the study at any time during the clinical investigation; * Individuals in period of exclusion from another protocol or currently participating in another interventional research study; * Individuals not able to understand and speak the official language of the research center; * Vulnerable individuals according to local legislation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sleep apnea syndromes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sleep apnea syndromes

Contacts and locations

Locations

  • Centre du sommeil, hôpital Bichat

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.